Categories: The Charlton Centre

Impact on the brain by inflammatory conditions

Today we bring you another update from the recent European Rheumatology Conference: EULAR that our Pharmacy Manager Carolyn Whiskin attended in June.

Inflammation can have an impact on memory and emotional well-being. It is well known that when inflammation is high there is an increase in depression. Rheumatoid arthritis treatments are less successful in those that are depressed, as inflammation affects the nervous system.

One study of patients with rheumatoid arthritis showed an improvement in dementia when on methotrexate.

When cognitive behavioural therapy was used and depression levels fell, there was a decrease in pain and fatigue, and markers of inflammation in the blood decreased as well. Biological therapies used to treat rheumatoid arthritis, although having great impact on joints, are not as successful at lowering depression. So it appears that depression must be managed independently in people who have rheumatoid arthritis to ensure the best outcomes for both mental health, pain and inflammation.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Share
Published by
admin

Recent Posts

Happy Back-to-School!

This week, many will return to school, and it's no secret that the back-to-school season…

2 weeks ago

Staying Hydrated in the Summer

Staying well hydrated is important in every season, but it becomes especially crucial during thesummer.…

3 weeks ago

World Hepatitis Day

Last week, on July 28th, we observed World Hepatitis Day, a day dedicated to raising…

1 month ago

Traveling This Summer with Biologics? Here’s What You Need to Know

Summer is a great time to get out and see new sights. Whether you're planning…

2 months ago

Summer Sun Safety

Now that the warmer weather is here, many of us are spending more time enjoying…

2 months ago

New Biosimilars of Xolair and Actemra Now Available: Omlyclo and Tyenne

Biosimilars are becoming more common in Canada, offering patients trusted alternatives to the originator biologic medication. Biosimilars…

3 months ago